Downregulation of MAGI1 Associates with Poor Prognosis of Hepatocellular Carcinoma

ABSTRACT Objective: MAGI1 (membrane-associated guanylate kinase, WW and PDZ domain containing 1) plays an important role in stabilization of adherens junctions and suppression of invasiveness and metastasis. However, its expression and clinical revelance in hepatocellular carcinoma (HCC) are still unknown. So, this study was performed to detect the expression and clinical significance of MAGI1 in human HCC. Methods: The mRNA and protein expression levels were examined by using reverse transcription-PCR (RT-PCR) and Western blotting in 31 paired HCC and paracarcinomatous liver tissues (PCLT). Furthermore, samples of 104 HCC patients were determined immunohistochemically for MAGI1 expression and the correlation of MAGI1 levels with prognosis was analyzed. Results: The expression levels of MAGI1 were significantly downregulated in HCCs than those in PCLTs (p < .01). Importantly, the decreased expression of MAGI1 correlated with multiple tumor nodules (p < .05), absence of capsular formation (p < .05), worse Edmondson–Steiner grade (p < .05), vein invasion (p < .01), shortened median overall survival time (25 versus 42 months; p = .013), and disease-free survival time (20 versus 40 months; p = .018) of HCC. Multivariable Cox regression analysis revealed that MAGI1 expression level was an independent factor for prognosis (p = .038). Conclusions: MAGI1 expression is decreased in HCC, which correlates with poor prognosis, suggesting MAGI1 as a novel prognostic marker for HCC.

[1]  M. Mareel,et al.  The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness , 2001, The Journal of cell biology.

[2]  S. Kawasaki,et al.  Hepatic resection for hepatocellular carcinoma -- Japanese experience. , 1998, Hepato-gastroenterology.

[3]  M. Beckerle,et al.  TRIP6, a novel molecular partner of the MAGI‐1 scaffolding molecule, promotes invasiveness , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  Y. Oshika,et al.  Vascularization is decreased in pulmonary adenocarcinoma expressing brain-specific angiogenesis inhibitor 1 (BAI1). , 2000, International journal of molecular medicine.

[5]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[6]  Y. Nakamura,et al.  Cloning and characterization of BAP3 (BAI-associated protein 3), a C2 domain-containing protein that interacts with BAI1. , 1998, Biochemical and biophysical research communications.

[7]  T. Pawlik,et al.  Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. , 2005, Archives of surgery.

[8]  F. Farinati,et al.  How should patients with hepatocellular carcinoma be staged? , 2000, Cancer.

[9]  Yusuke Nakamura,et al.  Localization of membrane-associated guanylate kinase (MAGI)-1/BAI-associated protein (BAP) 1 at tight junctions of epithelial cells , 1999, Oncogene.

[10]  Minh N. H. Nguyen,et al.  Requirement of PDZ-Containing Proteins for Cell Cycle Regulation and Differentiation in the Mouse Lens Epithelium , 2003, Molecular and Cellular Biology.

[11]  P. Bhathal,et al.  Endothelin‐induced vasoconstriction in isolated perfused liver preparations from normal and cirrhotic rats , 1997, Journal of gastroenterology and hepatology.

[12]  Y. Nakamura,et al.  Cloning and characterization of BAI-associated protein 1: a PDZ domain-containing protein that interacts with BAI1. , 1998, Biochemical and biophysical research communications.

[13]  Y. Sakamoto,et al.  A long‐term follow‐up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy , 2005, Cancer.

[14]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[15]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[16]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[17]  Katja Luck,et al.  The structural and dynamic response of MAGI-1 PDZ1 with noncanonical domain boundaries to the binding of human papillomavirus E6. , 2011, Journal of molecular biology.

[18]  M. Mareel,et al.  Implication of the MAGI‐1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  S. Fan,et al.  Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. , 1999, Annals of surgery.

[20]  K. Okuda.  Hepatocellular carcinoma: Clinicopathological aspects , 1997, Journal of gastroenterology and hepatology.

[21]  J. Issa,et al.  Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia , 2008, Leukemia.

[22]  S. Fan,et al.  Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma , 2000, Cancer.

[23]  G. Ercolani,et al.  Prognostic Evaluation of the New American Joint Committee on Cancer/International Union Against Cancer Staging System for Hepatocellular Carcinoma: Analysis of 112 Cirrhotic Patients Resected for Hepatocellular Carcinoma , 2005, Annals of Surgical Oncology.

[24]  S. Fan,et al.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. , 2000, Annals of surgery.

[25]  D. Gotley,et al.  Tumor progression in hepatocellular carcinoma: Relationship with tumor stroma and parenchymal disease , 2003, Journal of gastroenterology and hepatology.

[26]  S. Butz,et al.  Endothelial adhesion molecule ESAM binds directly to the multidomain adaptor MAGI-1 and recruits it to cell contacts. , 2004, Experimental cell research.

[27]  M. Wigler,et al.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.